Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury - (NOSTRA Phase III Trial): A Confirmatory, Placebo-controlled, Randomised, Double Blind, Multi-centre Study

NCT02794168 is registered in ClinicalTrials.gov with veriNOS operations GmbH as lead sponsor.

NCT NCT02794168
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02794168 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of VAS203 (Ronopterin) in Patients With Moderate and Severe Traumatic Brain Injury - (NOSTRA Phase III Trial): A Confirmatory, Placebo-controlled, Randomised, Double Blind, Multi-centre Study
Lead sponsor
veriNOS operations GmbH
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2016
Completion date
June 30, 2020
Enrollment
224 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury